Decreased endogenous nitric oxide production in acute decompensated heart failure with a reduced ejection fraction
Abstract Aims Heart failure represents a substantial burden to both patients and healthcare systems worldwide. Nitric oxide (NO) dysregulation may play a key role in patients transitioning from chronic to acute heart failure with a reduced ejection fraction (HFrEF). Plasma nitrite (NO2−) is highly r...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | ESC Heart Failure |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/ehf2.15253 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849311904957202432 |
|---|---|
| author | Roman Falls Bing H. Wang Sara Vogrin Christopher J. Neil |
| author_facet | Roman Falls Bing H. Wang Sara Vogrin Christopher J. Neil |
| author_sort | Roman Falls |
| collection | DOAJ |
| description | Abstract Aims Heart failure represents a substantial burden to both patients and healthcare systems worldwide. Nitric oxide (NO) dysregulation may play a key role in patients transitioning from chronic to acute heart failure with a reduced ejection fraction (HFrEF). Plasma nitrite (NO2−) is highly reflective of local nitric oxide production and has not been studied in acute HFrEF. This study aims to quantify measures of NO biology in patients with acute and chronic HFrEF. Methods and results We utilized gas‐phase chemiluminescence to determine plasma NO2− concentrations. Plasma asymmetric dimethylarginine (ADMA) and arterial stiffness were also measured. Plasma concentrations of NO2− and ADMA, in addition to arterial stiffness, were compared in participants with chronic HFrEF (n = 25) and acute HFrEF (n = 24). We observed lower concentrations of plasma NO2− in patients with acute HFrEF (P = 0.047). We also observed higher plasma concentrations of ADMA in participants with acute HFrEF (P < 0.001). Plasma NO2− and ADMA also displayed a significant negative correlation in the total cohort (Rs = −0.38, P = 0.017). There was no significant difference between groups regarding arterial stiffness measures. Conclusions We present novel data with regard to plasma NO2− in both acute and chronic HFrEF. Our results indicate that patients with acute HFrEF have a relative deficiency of plasma NO2− whilst also displaying a relative increase in ADMA, a modulator of eNOS. Reduced NO bioavailability may therefore relate to impaired NO production in patients with acute decompensation, with implications for both treatment and prevention of episodes. |
| format | Article |
| id | doaj-art-d18ad7afcf4445b6a0b839aaec0e6390 |
| institution | Kabale University |
| issn | 2055-5822 |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | ESC Heart Failure |
| spelling | doaj-art-d18ad7afcf4445b6a0b839aaec0e63902025-08-20T03:53:16ZengWileyESC Heart Failure2055-58222025-06-011232278228610.1002/ehf2.15253Decreased endogenous nitric oxide production in acute decompensated heart failure with a reduced ejection fractionRoman Falls0Bing H. Wang1Sara Vogrin2Christopher J. Neil3School of Health and Biomedical Sciences RMIT University Melbourne AustraliaBaker Heart and Diabetes Institute Melbourne VIC AustraliaDepartment of Medicine University of Melbourne‐Western Health Melbourne VIC AustraliaBaker Heart and Diabetes Institute Melbourne VIC AustraliaAbstract Aims Heart failure represents a substantial burden to both patients and healthcare systems worldwide. Nitric oxide (NO) dysregulation may play a key role in patients transitioning from chronic to acute heart failure with a reduced ejection fraction (HFrEF). Plasma nitrite (NO2−) is highly reflective of local nitric oxide production and has not been studied in acute HFrEF. This study aims to quantify measures of NO biology in patients with acute and chronic HFrEF. Methods and results We utilized gas‐phase chemiluminescence to determine plasma NO2− concentrations. Plasma asymmetric dimethylarginine (ADMA) and arterial stiffness were also measured. Plasma concentrations of NO2− and ADMA, in addition to arterial stiffness, were compared in participants with chronic HFrEF (n = 25) and acute HFrEF (n = 24). We observed lower concentrations of plasma NO2− in patients with acute HFrEF (P = 0.047). We also observed higher plasma concentrations of ADMA in participants with acute HFrEF (P < 0.001). Plasma NO2− and ADMA also displayed a significant negative correlation in the total cohort (Rs = −0.38, P = 0.017). There was no significant difference between groups regarding arterial stiffness measures. Conclusions We present novel data with regard to plasma NO2− in both acute and chronic HFrEF. Our results indicate that patients with acute HFrEF have a relative deficiency of plasma NO2− whilst also displaying a relative increase in ADMA, a modulator of eNOS. Reduced NO bioavailability may therefore relate to impaired NO production in patients with acute decompensation, with implications for both treatment and prevention of episodes.https://doi.org/10.1002/ehf2.15253Nitric oxidePlasma nitriteHeart failure with a reduced ejection fractionAsymmetric dimethylarginine |
| spellingShingle | Roman Falls Bing H. Wang Sara Vogrin Christopher J. Neil Decreased endogenous nitric oxide production in acute decompensated heart failure with a reduced ejection fraction ESC Heart Failure Nitric oxide Plasma nitrite Heart failure with a reduced ejection fraction Asymmetric dimethylarginine |
| title | Decreased endogenous nitric oxide production in acute decompensated heart failure with a reduced ejection fraction |
| title_full | Decreased endogenous nitric oxide production in acute decompensated heart failure with a reduced ejection fraction |
| title_fullStr | Decreased endogenous nitric oxide production in acute decompensated heart failure with a reduced ejection fraction |
| title_full_unstemmed | Decreased endogenous nitric oxide production in acute decompensated heart failure with a reduced ejection fraction |
| title_short | Decreased endogenous nitric oxide production in acute decompensated heart failure with a reduced ejection fraction |
| title_sort | decreased endogenous nitric oxide production in acute decompensated heart failure with a reduced ejection fraction |
| topic | Nitric oxide Plasma nitrite Heart failure with a reduced ejection fraction Asymmetric dimethylarginine |
| url | https://doi.org/10.1002/ehf2.15253 |
| work_keys_str_mv | AT romanfalls decreasedendogenousnitricoxideproductioninacutedecompensatedheartfailurewithareducedejectionfraction AT binghwang decreasedendogenousnitricoxideproductioninacutedecompensatedheartfailurewithareducedejectionfraction AT saravogrin decreasedendogenousnitricoxideproductioninacutedecompensatedheartfailurewithareducedejectionfraction AT christopherjneil decreasedendogenousnitricoxideproductioninacutedecompensatedheartfailurewithareducedejectionfraction |